In breast cancer, miR-27b has been reported to target the 3′ untranslated region (3′UTR) region of pyruvate dehydrogenase complex component X (PDHX), limiting the conversion of pyruvate in the tricarboxylic acid cycle (TCA) [40]. Here, PDHX is linked to breast cancer.